Evidence map›Paper›PMID 38239567›Full record

ArticleConsortium psychiatricum2023

Efficacy of a Relaxation Scenario in Virtual Reality for the Comorbid Symptoms of Anxiety and Asthenia in a General Hospital Setting: A Pilot Comparative Randomized Open-Label Study.

Taisiya А Lepilkina, Allan G Beniashvili, Roman A Cheremin, Natalya G Malyukova, Margarita A Morozova, Mikhail A Bogdanov, Denis S Burminsky, Sergei S Potanin, Svetlana V Rodkina, George E Rupchev and 1 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Consortium psychiatricum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Taisiya А LepilkinaMental Health Research Center.ORCID https://orcid.org/0000-0002-2640-4658
Allan G BeniashviliMental Health Research Center.ORCID https://orcid.org/0000-0002-5149-3760
Roman A ChereminSpeech Pathology and Neurorehabilitation Center.ORCID https://orcid.org/0000-0001-6018-6327
Natalya G MalyukovaSpeech Pathology and Neurorehabilitation Center.ORCID https://orcid.org/0000-0003-1142-0804
Margarita A MorozovaMental Health Research Center.ORCID https://orcid.org/0000-0002-7847-2716
Mikhail A BogdanovSpeech Pathology and Neurorehabilitation Center.ORCID https://orcid.org/0000-0002-5033-7221
Denis S BurminskyMental Health Research Center.ORCID https://orcid.org/0000-0001-7098-2570
Sergei S PotaninMental Health Research Center.ORCID https://orcid.org/0000-0002-9180-1940
Svetlana V RodkinaSpeech Pathology and Neurorehabilitation Center.ORCID https://orcid.org/0000-0002-0478-1380
George E RupchevMental Health Research Center.ORCID https://orcid.org/0000-0002-4440-095X
Margarita N EipSpeech Pathology and Neurorehabilitation Center.ORCID https://orcid.org/0000-0001-8666-5019
Center for Speech Pathology and Neurorehabilitation · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients in general hospitals often display concomitant signs of mental maladjustment: low mood, anxiety, apathy, asthenia, all of which can have a negative impact on the course of the underlying disease and the recovery process. One of the non-pharmacological approaches that has gained wider acceptance in medical practice in recent years is the use of procedures based on virtual reality.

aimAssess the efficacy of the new domestic, virtual reality application Flow as relates to symptoms of anxiety and asthenia in patients undergoing inpatient treatment.

methodsThe study was open-label and had a comparison group; the patients were assigned to the experimental or control group using a randomization table. The patients were assessed using the Spielberger State Anxiety Inventory; the Fatigue Symptom Rating Scale; the Well-being, Activity, Mood questionnaire; the Depression Anxiety Stress Scale; and the Clinical Global Impression Scale. Physical parameters were measured before and after each virtual reality session. The obtained data were statistically processed.

resultsThe study involved 60 patients. In 40 patients, the treatment program included a course of five daily relaxation sessions in virtual reality; the control group consisted of 20 patients, who were treated in accordance with the usual practice of the institution. The addition of virtual reality sessions to the standard treatment course yielded significant advantage in terms of affective symptoms reduction in patients both after a single session and as a result of undergoing the full course, and several days after its completion. The patients in the experimental group also showed a significant decrease in blood pressure after the sessions, and this was most pronounced in individuals who initially had elevated and high blood pressure.

conclusionThe use of relaxation program courses in the virtual reality application Flow is an effective and promising means of non-pharmacological care for non-psychiatric inpatients showing symptoms of anxiety, apathy, depressive mood, as well as hypertension.

Indexed as

comorbid mental symptomslowering blood pressuremaladjustment reactionnon-pharmacological therapyvirtual reality

Identifiers

PMID38239567
PMCPMC10790732
OpenAlexW4327740123

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.